Testing Nivolumab in Combination With Decitabine and Venetoclax in Patients With Newly Diagnosed TP53 Gene Mutated Acute Myeloid Leukemia

Condition:   Acute Myeloid Leukemia Interventions:   Drug: Decitabine;   Biological: Nivolumab;   Drug: Venetoclax Sponsor:   National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials